Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.75 Billion SEK | 3.87% |
| 2022 | 9.52 Billion SEK | 2.29% |
| 2021 | 9.31 Billion SEK | -4.58% |
| 2020 | 9.76 Billion SEK | 0.02% |
| 2019 | 9.75 Billion SEK | -13.92% |
| 2018 | 11.33 Billion SEK | 35.84% |
| 2017 | 8.34 Billion SEK | -18.33% |
| 2016 | 10.21 Billion SEK | -4.89% |
| 2015 | 10.74 Billion SEK | 15.98% |
| 2014 | 9.26 Billion SEK | 3.37% |
| 2013 | 8.96 Billion SEK | 5.81% |
| 2012 | 8.47 Billion SEK | 16.0% |
| 2011 | 7.3 Billion SEK | -2.67% |
| 2010 | 7.5 Billion SEK | -4.91% |
| 2009 | 7.88 Billion SEK | 217.55% |
| 2008 | -6.71 Billion SEK | -223.86% |
| 2007 | 5.41 Billion SEK | 30.65% |
| 2006 | 4.14 Billion SEK | 13.15% |
| 2005 | 3.66 Billion SEK | 10.35% |
| 2004 | 3.32 Billion SEK | -38.17% |
| 2003 | 5.37 Billion SEK | 10.42% |
| 2002 | 4.86 Billion SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.75 Billion SEK | -3.37% |
| 2024 Q1 | 2.84 Billion SEK | 4.21% |
| 2024 Q3 | 3.21 Billion SEK | 22.49% |
| 2023 Q2 | 2.65 Billion SEK | 2.31% |
| 2023 Q1 | 2.59 Billion SEK | -6.41% |
| 2023 Q4 | 2.73 Billion SEK | 26.06% |
| 2023 Q3 | 2.16 Billion SEK | -18.43% |
| 2023 FY | 9.89 Billion SEK | 3.87% |
| 2022 Q1 | 2.25 Billion SEK | -25.65% |
| 2022 Q4 | 2.77 Billion SEK | 22.89% |
| 2022 FY | 9.52 Billion SEK | 2.29% |
| 2022 Q3 | 2.25 Billion SEK | 0.98% |
| 2022 Q2 | 2.23 Billion SEK | -0.8% |
| 2021 Q4 | 3.03 Billion SEK | 48.6% |
| 2021 FY | 9.31 Billion SEK | -4.58% |
| 2021 Q3 | 2.04 Billion SEK | -7.65% |
| 2021 Q2 | 2.21 Billion SEK | 8.87% |
| 2021 Q1 | 2.03 Billion SEK | -20.2% |
| 2020 Q4 | 2.54 Billion SEK | 14.85% |
| 2020 Q2 | 2.53 Billion SEK | 2.63% |
| 2020 Q1 | 2.46 Billion SEK | -2.06% |
| 2020 FY | 9.76 Billion SEK | 0.02% |
| 2020 Q3 | 2.21 Billion SEK | -12.55% |
| 2019 Q3 | 2.45 Billion SEK | 0.53% |
| 2019 Q4 | 2.52 Billion SEK | 2.82% |
| 2019 Q1 | 2.35 Billion SEK | -2.61% |
| 2019 Q2 | 2.43 Billion SEK | 3.74% |
| 2019 FY | 9.75 Billion SEK | -13.92% |
| 2018 Q3 | 4.12 Billion SEK | 84.44% |
| 2018 Q2 | 2.23 Billion SEK | -12.79% |
| 2018 Q1 | 2.56 Billion SEK | 1019.65% |
| 2018 FY | 11.33 Billion SEK | 35.84% |
| 2018 Q4 | 2.41 Billion SEK | -41.49% |
| 2017 Q3 | 2.69 Billion SEK | -2.28% |
| 2017 FY | 8.34 Billion SEK | -18.33% |
| 2017 Q4 | 229 Million SEK | -91.51% |
| 2017 Q1 | 2.65 Billion SEK | 1.68% |
| 2017 Q2 | 2.76 Billion SEK | 3.88% |
| 2016 Q3 | 2.48 Billion SEK | -2.55% |
| 2016 Q4 | 2.61 Billion SEK | 5.06% |
| 2016 FY | 10.21 Billion SEK | -4.89% |
| 2016 Q2 | 2.55 Billion SEK | -0.43% |
| 2016 Q1 | 2.56 Billion SEK | -5.77% |
| 2015 FY | 10.74 Billion SEK | 15.98% |
| 2015 Q4 | 2.72 Billion SEK | 4.49% |
| 2015 Q3 | 2.6 Billion SEK | -7.2% |
| 2015 Q2 | 2.8 Billion SEK | 7.3% |
| 2015 Q1 | 2.61 Billion SEK | 10.34% |
| 2014 FY | 9.26 Billion SEK | 3.37% |
| 2014 Q2 | 2.33 Billion SEK | 3.73% |
| 2014 Q1 | 2.25 Billion SEK | 3.02% |
| 2014 Q4 | 2.37 Billion SEK | 2.91% |
| 2014 Q3 | 2.3 Billion SEK | -1.5% |
| 2013 FY | 8.96 Billion SEK | 5.81% |
| 2013 Q4 | 2.18 Billion SEK | -0.5% |
| 2013 Q3 | 2.19 Billion SEK | -3.09% |
| 2013 Q2 | 2.26 Billion SEK | -1.6% |
| 2013 Q1 | 2.3 Billion SEK | 2.9% |
| 2012 Q4 | 2.24 Billion SEK | 9.91% |
| 2012 Q1 | 2.05 Billion SEK | 1.38% |
| 2012 Q2 | 2.13 Billion SEK | 4.34% |
| 2012 FY | 8.47 Billion SEK | 16.0% |
| 2012 Q3 | 2.03 Billion SEK | -4.68% |
| 2011 Q4 | 2.02 Billion SEK | 17.22% |
| 2011 FY | 7.3 Billion SEK | -2.67% |
| 2011 Q1 | 1.79 Billion SEK | -5.97% |
| 2011 Q2 | 1.76 Billion SEK | -1.78% |
| 2011 Q3 | 1.72 Billion SEK | -2.1% |
| 2010 Q3 | 1.78 Billion SEK | -9.44% |
| 2010 Q2 | 1.97 Billion SEK | 7.24% |
| 2010 Q1 | 1.83 Billion SEK | -8.78% |
| 2010 FY | 7.5 Billion SEK | -4.91% |
| 2010 Q4 | 1.9 Billion SEK | 6.89% |
| 2009 Q2 | 1.98 Billion SEK | -1.44% |
| 2009 FY | 7.88 Billion SEK | 217.55% |
| 2009 Q1 | 2.01 Billion SEK | 0.0% |
| 2009 Q4 | 2.01 Billion SEK | 6.9% |
| 2009 Q3 | 1.88 Billion SEK | -4.85% |
| 2008 FY | -6.71 Billion SEK | -223.86% |
| 2007 FY | 5.41 Billion SEK | 30.65% |
| 2006 FY | 4.14 Billion SEK | 13.15% |
| 2005 FY | 3.66 Billion SEK | 10.35% |
| 2004 FY | 3.32 Billion SEK | -38.17% |
| 2003 FY | 5.37 Billion SEK | 10.42% |
| 2002 FY | 4.86 Billion SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AVITA Medical, Inc. | 80.77 Million USD | -13219.02% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -1530340.967% |
| Össur hf. | 396.18 Million USD | -2615.644% |
| QHSLab, Inc. | 961.65 Thousand USD | -1118702.728% |
| Wellstar International, Inc. | 1.79 Million USD | -599388.716% |
| Össur hf. | 396.18 Million USD | -2615.644% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | -204807.261% |
| Aurora Spine Corporation | 8.65 Million USD | -124173.923% |
| BrainsWay Ltd. | 28.01 Million USD | -38300.314% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -1452491.957% |
| Hamilton Thorne Ltd. | 33.57 Million USD | -31946.997% |
| Vivos Inc. | 2.78 Million USD | -385927.103% |
| Kelyniam Global, Inc. | 2.27 Million USD | -472772.36% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -1060001.31% |
| Zecotek Photonics Inc. | 3.46 Million USD | -310723.858% |
| Avitar, Inc. | 3.56 Million USD | -301313.666% |
| Nanomix Corporation | 8.36 Million USD | -128477.592% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | -49303.067% |
| Theraclion SA | 7.43 Million USD | -144513.481% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | -1068018.755% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -345798.948% |
| Lombard Medical, Inc. | 30.29 Million USD | -35419.974% |
| ALR Technologies Inc. | 6.33 Million USD | -169707.557% |
| Stratec SE | 46.32 Million USD | -23127.357% |
| Vycor Medical, Inc. | 1.27 Million USD | -843436.818% |
| Heart Tronics, Inc. | 14.46 Million USD | -74304.824% |
| MicroPort Scientific Corporation | 1.04 Billion USD | -926.364% |
| VMS Rehab Systems, Inc. | 63.63 USD | -16908690769.087% |
| NewCardio, Inc. | 9.56 Million USD | -112390.773% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -307916.032% |
| Ingen Technologies, Inc. | 1.88 Million USD | -571511.941% |
| Odyssey Group International, Inc. | -14.26 Million USD | 75543.121% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -2470393.685% |
| Wellness Center USA, Inc. | 1.29 Million USD | -830981.634% |
| SANUWAVE Health, Inc. | 14.15 Million USD | -75929.963% |
| IR-Med Inc. | 4.89 Million USD | -219740.621% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -5212113.992% |
| Polarean Imaging plc | 12.24 Million USD | -87782.664% |
| United American Healthcare Corporation | 59 Thousand USD | -18235493.22% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -2640242.589% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -8926604.611% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -1695063.608% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -634437.75% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -814669.602% |
| Urologix, Inc. | 10.09 Million USD | -106509.195% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -851536.109% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -180775.147% |
| SS Innovations International, Inc. | 21.38 Million USD | -50218.448% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -4672829.669% |
| Smith & Nephew plc | 3.46 Billion USD | -210.326% |
| NIOX Group Plc | 22.27 Million USD | -48195.365% |
| Fuse Medical, Inc. | 10.35 Million USD | -103851.54% |
| Broncus Holding Corporation | 38.15 Million USD | -28101.062% |
| Brain Scientific Inc. | 9.66 Million USD | -111245.321% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -104326.706% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -17725360.476% |